Eriseld Krasniqi

KEAP1-driven co-mutations in lung adenocarcinoma unresponsive to immunotherapy despite high tumor mutational burden

Daniele Marinelli, Marco Mazzotta, Stefano Scalera et al. · Annals of Oncology · 2020 · 218 citations · Full text

Medicine, Lung Adenocarcinoma, Immunology +7

KEAP1 and TP53 Frame Genomic, Evolutionary, and Immunologic Subtypes of Lung Adenocarcinoma With Different Sensitivity to Immunotherapy

Stefano Scalera, Marco Mazzotta, Giacomo Corleone et al. · Journal of Thoracic Oncology · 2021 · 76 citations

Tp53 Frame Genomic, Cancer Immunosurveillance, Lung Adenocarcinoma +7

Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER Study

Giulia Bon, Laura Pizzuti, Valentina Laquintana et al. · Journal of Experimental & Clinical Cancer Research · 2020 · 72 citations · Full text

KEAP1-Mutant NSCLC: The Catastrophic Failure of a Cell-Protecting Hub

Stefano Scalera, Marco Mazzotta, Clelia Cortile et al. · Journal of Thoracic Oncology · 2022 · 60 citations · Full text

Cell Regulation, Cell Division, Natural Sciences +8

The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial

Laura Pizzuti, Maddalena Barba, Marco Mazzotta et al. · Scientific Reports · 2021 · 42 citations · Full text